|
Education
- University of Maryland, College Park B.A. 1958-1962 Philosophy
- University of Maryland, Baltimore M.D. 1962-1966 Medicine
- University of Maryland Hospital, Baltimore Internship 1966-1967 Medicine
- U.S. Public Health Service Military 1967-1969 Lt. Commander
- University of Florida, Gainesville Residency 1969-1972 Ophthalmology
- The Johns Hopkins University, Baltimore Fellowship 1972-1973 NIH Special Fellow
Faculty Appointments
- 1973-1990 The Wilmer Ophthalmological Institute, The Johns Hopkins University School of Medicine
- 1974-1990 Director of Undergraduate Education in Ophthalmology, The Johns Hopkins University School of Medicine
- 1976-1983 Fellowship Program Director, Retinal Vascular Center, The Johns Hopkins University School of Medicine
- 1979-1990 Director, Retinal Vascular Center, The Wilmer Institute, The Johns Hopkins University School of Medicine
- 1982-1990 Professor of Ophthalmology, The Johns Hopkins University School of Medicine
- 1991-present Chairman, Professor of Ophthalmology, and Director of the Scheie Eye Institute, The University of Pennsylvania School of Medicine, Philadelphia
Selected NIH Grant Support
- 1979-1994 Study Chair, Macular Photocoagulation Study (16 clinical centers; documented benefit of laser treatment for selected patients with neovascular stage of age-related macular degeneration)
- 1985-present Study Chair, Collaborative Ocular Melanoma Study (43 clinical centers; ongoing evaluation of management strategies for patients with eye melanoma)
- 1994-1999 Study Chair, Choroidal Neovascularization Prevention Trial (16 clinical centers; pilot trial to evaluate preventive treatment for early stage of age-related macular degeneration)
- 1999-present Study Chair, Complications of AMD Prevention Trial (22 clinical centers; definitive trial to evaluate preventive treatment for early stage of age-related macular degeneration
- 1999-present Principal Investigator and Study Chair, AMD and Radiotherapy Trial (12 clinical centers; pilot trial to assess radiation treatment for neovascular stage of age-related macular degeneration)
Selected Honors
- 1982 Professors' Award for Excellence in Teaching, The Johns Hopkins University School of Medicine
- 1995 J. Donald M. Gass, M.D. Award for Outstanding Contributions to Macular Research, Macula Society
- 1996 Retina Research Fund Award of Merit (Awarded by the Retina Research Fund and the Retina Society for Lifetime Contributions to Retina Research)
- 1998-2000 President, Association of University Professors of Ophthalmology
- 2000 Sir Norman Gregg Medal, Royal Australian and New Zealand College of Ophthalmology
Selected Publications 1994-present
- Bressler NM, Silva JC, Bressler SB, Fine SL, Green WR. Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration. Retina 14:130-142, 1994.
- Macular Photocoagulation Study Group: Five-year follow-up of fellow eyes of individuals with ocular histoplasmosis and unilateral extrafoveal or juxtafoveal choroidal neovascularization. Arch Ophthalmol, 114(6):677-688, 1996.
- Macular Photocoagulation Study Group (prepared by Bressler NM, Marsh MJ, Maguire MG, Alexander J, Phillips DA, Javornik NB, Hiner ML, Lewis ML, Schachat AP, Singerman LJ, Stevens TS, Hawkins BS, Fine SL). Occult choroidal neovascularization: Influence on visual outcome in patients with age-related macular degeneration. Arch Ophthalmol, 114(4):400-12, 1996 Apr.
- Fine SL. No one knows the preferred management for choroidal melanoma. (Editorial). Am. J. Ophthalmology 122(1):106-108, 1996.
- Stevens TS, Bressler NM, Maguire MG, Bressler SB, Fine SL, et al: Occult choroidal neovascularization in age-related macular degeneration: A natural history study of morphologic changes. Arch Ophthalmol. 115:345-350, 1997.
- Macular Photocoagulation Study Group: Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Arch Ophthalmol.,115:741-747, 1997.
- Collaborative Ocular Melanoma Study Group. COMS Report No. 4. Mortality in patients with small choroidal melanoma. Arch Ophthalmol., 115:886-893, 1997.
- Fine SL, Maguire MG. We are very spoiled. (Editorial). Arch Ophthalmol., 115:915-916, 1997.
- Collaborative Ocular Melanoma Study Group. COMS Report No. 5. Factors Predictive of Growth and Treatment of Small Choroidal Melanoma. Arch Ophthalmol., 115:1537-1544, 1997.
- Choroidal Neovascularization Prevention Trial Research Group (prepared by Maguire MG, Fine SL, Ho AC, Javornik NB). Laser treatment in eyes with large drusen: short term effects from a pilot randomized clinical trial. Ophthalmol. 105:11-23, 1998.
- Collaborative Ocular Melanoma Study Group. COMS Report No. 10. Randomized trial of pre-enucleation radiation of large choroidal melanoma II: Initial mortality findings. Am. J. Ophthalmol. 125: 779-796, 1998.
- Lanchoney DM, Maguire MG, Fine SL. A model of incidence and consequences of choroidal neovascularization secondary to age-related macular degeneration. Arch Ophthalmol., 116: 1045-1052, 1998.
- Berger, JW, Fine SL, Maguire MG Age-related Macular Degeneration (textbook), CV Mosby Co., 1998
- Fine SL. Macular Hole: A Continuing Saga. (Editorial) Arch Ophthalmol., 117: 248-249, 1999.
- Fine SL, Berger JW, Maguire MG, Ho AC. Age-related macular degeneration. The New England Journal of Medicine, 342:7,483, 1999.
- Kaiser RS, Maguire MG, Grunwald JE, Lieb D, Jani B, Brucker AJ, Maguire AM, Ho AC, Fine, SL. One-year outcomes of panretinal photocoagulation in proliferative diabetic retinopathy. Am. J. Ophthalmol., 129:178-185, 2000.
- Fine, SL and Maguire, MG. It is not time to abandon radiotherapy for neovascular age-related macular degeneration. (Editorial) Arch Ophthalmol. 119: 275-276, 2001
- Kaiser RS, Berger JW, Maguire MG, Shin DS, Ho AC, Javornik NB, Fine SL and the Choroidal Neovascularization Prevention Trial Research Group. Laser burn intensity and the risk for choroidal neovascularization in the CNVPT Fellow Eye Study. Arch. Ophthalmology, 119: 826-832, 2001.
|
